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ABSTRACT 
 
     Metallo β-lactamases (MBLs) producing Pseudomonas aeruginosa (P. aeruginosa) isolates are 
becoming an escalating global threat. Among the antibiotics used to treat infections associated with P. 
aeruginosa, resistance to carbapenem is a serious therapeutic challenge. The aim of the present study 
was to detect MBL-producing P. aeruginosa and to evaluate the extracts of Urtica. dioica, Carum. 
copticum, and Zataria multiflora on these clinical pathogens. The study was performed on hospitalized 
burn patients during 2014. Antibiotic susceptibility testing was assessed by broth micro dilution and disc 
diffusion methods. The MBLs were detected using combination disk diffusion test (CDDT) 
phenotypically. Then, PCR and sequencing methods were carried out to detect the MBL encoding genes. 
Among 83 imipenem resistant P. aeruginosa strains, 48 (57.9%) isolates were MBL-producing P. 
aeruginosa. PCR and sequencing methods confirmed that these strains were blaIMP-1 positive genes, 
whereas none were positive for blaVIM genes. Hospitalized burn patients with MBL-producing 
P.aeruginosa infection had 4/48 (8.3%) mortality rate. It was demonstrated that C. copticum, U. dioica, 
and Z. multiflora extracts had significant antibacterial effects on regular and IMP-producing P. 
aeruginosa strains. The prevalence of MBL-producing P  . aeruginosa isolates in burn patients is 
generally very high. All MBL-producing strains encode the blaIMP-1 gene. Therefore, detection of MBL-
producing strains has major importance in identifying drug resistance patterns in P. aeruginosa and in 
controlling of infections. In the current study, the extracts from C. copticum, U. dioica, and Z. multiflora 
had high antibacterial effects against β-lactamase producing P. aeruginosa isolates. 
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INTRODUCTION 
     P. aeruginosa  is an opportunistic bacterium 
that causes different conditions such as 
septicemia, pneumonia, urinary tract infection 
(UTI), endocarditis, and skin-eye-ear infections 
[1]. This bacterium is one of the major causes of 
hospitalized infections and the main cause of 
death in patients with cystic fibrosis, severe 
burns, and AIDS [2]. P. aeruginosa is one 
global threat of hospitalized infections in the 
entire world [3]. It is estimated that about 
63,000 people in the U.S. and 25,000 in the 
E.U. die each year because of the infectious 
diseases caused by multi-drug resistant (MDR) 
bacteria [4]. MBLs are the genes causing 
resistance in P. aeruginosa. The MBL-encoding 
genes, blaIMP and blaVIM, which are often located 
on integrons, can easily spread among bacteria 
[5]. Both genes of imp and vim-type in P. 
aeruginosa clinical strains are often located on 
class 1 integrons [6]. The integrons are 
motionless per se, yet as they are located on 
transposons or plasmids, they would be mobile 
and thus can spread the resistance [7]. 
 
This is in line with the existence of herbal 
medicine that can possibly be helpful in 
treatment of infections produced by MDR 
isolates. Using herbs to treat diseases has long 
been common among mankind. Over the ages, 
the beneficial effects of various plants and herbs 
for treatment have been realized. Modern life has 
led to the reduction in consumption of medicinal 
plants. They are now replaced by synthetic drugs. 
Taking these drugs has unfortunately increased 
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the resistance of microorganisms and reduced the 
effects of medications [8].  
Treatment based on medicinal plants has 
commonly been cheaper, easier, and more 
accessible with fewer side effects in comparison 
with chemical compounds. On the other hand, 
people seem to be more inclined to use herbal 
remedies compared to chemical drugs [9].  
 C. copticum grows in east India, Egypt, and 
Iran, with brilliant flowers and brownish seeds, 
having an odour like thymol. Its essential oil 
includes β-pinene, paracymene, terpinene, α-
pinene, and other components such as thymol 
and carvacrol. The seeds are used as diuretic, 
analgesic, anti-asthmatic, anti-vomiting, and 
anti-dyspnea agents. This plant has a great 
effect on skin-related infections and urinary 
tract disorders [10-12]. U. dioica belongs to 
Urticacease family, an herb that has long been 
noted. In Europe, this herb is used to reduce 
inflammation and to treat rheumatoid arthritis 
[13, 14]. U. dioica in Iranian traditional medicine 
is used in the treatment of diabetes. This is an 
anti-inflammatory, blood sugar and blood 
pressure lowering, diuretic, analgesic, local 
anesthetic, anti-prostate inflammation plant. 
Recently, U. dioica has been used for the 
treatment of infectious diseases and reduction of 
arthritis symptoms and joint inflammation. Other 
medicinal uses of this herb are in the treatment of 
bladder and urinary tract infections, prostate 
enlargement, seasonal allergies, and acne [15]. U. 
dioica grows in the northern west and central 
parts of Iran. Its combinations include 
hydrophilic compounds such as flavonoids, 
lecithin, polysaccharides, acetic acid, and butyric 
acid. Z. multiflora, a member of the Labiatae 
family, is grown in Afghanistan, Pakistan, and 
Iran. Conventionally, it has been used to treat 
chronic catharsis, premenstrual pain, edema, sore 
throat, jaundice, and asthma. This herb is used as 
diuretic, antiseptic, flavoring, carminative, and as 
an antispasmodic agent. Z. multiflora has been 
described to have applicable medical properties 
including pain-relieving, immunostimulant, 
antibacterial, anticandidal, antifungal, 
antioxidant, antinociceptive, and anti-
inflammatory effects [16-18]. The aim of the 
present study is to detect MBL-producing P. 
aeruginosa by PCR and to evaluate the 
antibacterial effects of acetone and methanol 
extracts of U. dioica, C. copticum, and Z. 
multiflora, Iranian medicinal herbs, on P. 
aeruginosa clinical isolates. 
MATERIALS AND METHODS 
Collection and identification of bacteria 
     The current study was carried out on 448 
hospitalized burn patients who had referred to 
Shahid Motahari Hospital in Tehran, Iran. 
During the year 2011, 100 strains of P. 
aeruginosa were collected from these patients. 
Wounds were washed by physiological serum 
and then sampling was done using a sterile swab. 
The swabs were placed in Stuart transport 
medium and transferred to the laboratory of 
Microbiology Dept., Shahid Beheshti University 
of Medical Sciences, Tehran-Iran. The samples 
were cultured on Cetrimide and MacConkey agar 
and incubated at 37ºC for 24 hours. Colonies 
were evaluated for the presence of P. aeruginosa 
by the differential and diagnostic tests. 
Pigmented and odoriferous colonies were 
analyzed using biochemical tests, including 
oxidase, catalase, sugar fermentation, and growth 
ability at 42°C tests. The strains were placed at -
20ºC in brain heart broth, together with 20% 
glycerol. P.aeroginosa ATCC27853 was selected 
as the reference strain. 
Disk diffusion method 
     According to the guidelines of the CLSI [19], 
antibacterial susceptibility to selected antibiotics 
(Mast Group, Merseyside, UK) was tested on the 
P. aeruginosa isolates as well as the control 
ATCC27853 strain by disk diffusion method on 
Mueller Hinton agar (Merck, Germany) [19]. 
MBL detection was performed through 
Combination Disk Diffusion Test (CDDT). In 
this method, Imipenem and Imipenem plus 
EDTA discs were used to detect MBL producing 
P. aeruginosa. MDR is defined as resistance to 
three or more than three antibiotics from various 
classes. 
Antibiotics MIC determination  
     Sensitivity of 100 P. aeruginosa strains was 
performed based on the minimum inhibitory 
concentration (MIC) by broth micro dilution 
method according to CLSI guidelines [19]. 
Certain doses of imipenem, meropenem, 
aztreonam, cefotaxime, and ceftazidime were 
added to the Muller Hinton agar (GLAXO 
England Co. and Himedia Co.).  
A total of 10 ml of bacterial suspension was 
inoculated on Mueller-Hinton agar medium 
containing different dilutions of drugs using 
inoculators hand apparatus (Co MAST). Plates 
were examined after incubation at 37°C for 18 
hours. 
 
 
Journal of Paramedical Sciences (JPS)                Winter 2016 Vol 7, No1. ISSN 2008-4978 
 
31 
 
PCR and Sequencing 
    Polymerase chain reaction (PCR) method was 
performed for detection of blaVIM and blaIMP genes 
in P. aeruginosa strains by using of temperature 
and the genes specific primers. Half µl of 
extracted DNA plus 0.5 µl from each primer were 
uses. PCR master mix was then added to each 
tube (South Korea Bioneer Company) to a final 
volume of 20 µl.  
The PCR amplification for blaIMP and blaVIM was 
done with Primers VIM-F (5′-
GTTTGGTCGCATATCGCAAC-3′) and VIM-R 
(AATGCGCAGCACCAGGATAG-3′) for blaVIM 
gene and primers IMP-F (5′- 
GAAGGCGTTTATGTTCATAC-3′) and IMP-R 
(5′-GTATGTTTCAAGAGTGATGC-3′) for 
blaIMP gene under PCR conditions, as previously 
reported (20). The PCR purification kit (Bioneer 
Co., Korea) was used to purify PCR products and 
sequencing was performed by the Bioneer 
company (Korea). The nucleotide sequences were 
analyzed by Chromas 1.45 and MEGA-4 as well 
as BLAST in NCBI. 
Collection and Identification of Plants 
    During the year 2012, U. dioica, and Z. 
multiflora leaves and C. copyicum seeds were 
collected from Fars and Guilan provinces in Iran. 
A voucher specimen was prepared and deposited 
at Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. 
Extraction Method 
    U. dioica and Z. multiflora leaves and C. 
copyicum seeds were dried at room temperature 
and powdered. Twenty grams of each powdered  
herb were solved in methanol and acetone 
solvents, and then placed in the dark for a period 
of 48 hours without heating. Next, it was purified 
and placed at room temperature to dry and was 
left at -20°C until performing the following tests. 
Extracts MIC Determination 
    The MIC of the extracts was evaluated 
according to the method reported by CLSI, 2012. 
C. copyicum, U. dioica, and Z. multiflora extracts 
were dissolved in DMSO 10% and then a certain 
amount of prepared solution was added to Mueller 
Hinton agar medium. Concentrations were mixed 
thoroughly in the media containing extracts. Ten 
µl of suspension (equivalent to 0.5 McFarland) 
was added to plates containing extracts and 
incubated at 37ºC for 24 hours. Finally, the effect 
of extracts was studied against P.aeruginosa 
strains isolated from burn patients.  
Statistical Analysis 
    The effect of Z. multiflora, U. dioica, and C. 
copticum extracts on P. aeruginosa was analyzed 
via one-way ANOVA using MINITAB (version 
13). A p value <0.05 was considered significant. 
 
RESULTS 
     Among 100 P. aeruginosa strains, 83 were 
imipenem and ceftazidime resistant. The CDDT 
demonstrated that from among 83 Imipenem 
resistant P. aeruginosa isolates, 48 (57.9%) were 
MBL producers. All MBL-producing P. 
aeruginosa isolates were resistant to ceftazidime, 
ceftriaxone, cefepime, meropenem, imipenem, 
amikacin, tobramycin, ciprofloxacin, aztreonam, 
piperacillin/tazobactam, and carbenicillin. The 
results showed that 100% of strains were MDR. 
The MIC of selected antibiotics for IMP-
producing P. aeruginosa strains are shown in 
Table 1. The results of PCR show that 6 strains 
were positive for blaIMP gene, while blaVIM gene 
was not detected.  
 
 
Table1. Distribution of antibiotics MICs for IMP-producing P.aeroginosa strains. 
 Antibiotics MIC
a
(µg/ml) 
P.a
b
 
FSH
c
2IMP
d
 
P.a  
FSH22IMP 
P.a 
FSH28IMP 
P.a 
FSH40IMP 
P.a 
FSH42IMP 
P.a 
FSH47IMP 
 
carbapenems 
imipenem 128 128 128 128 128 128 
meropenem 64 32 64 64 64 64 
 
 
cephalosporins 
cefepim 128 128 128 128 128 128 
ceftazidime ≥256 ≥256 ≥256 ≥256 ≥256 ≥256 
cefotaxime ≥256 ≥256 ≥256 ≥256 ≥256 ≥256 
ceftriaxon ≥256 ≥256 ≥256 ≥256 ≥256 ≥256 
 
penicillins 
ampicillin ≥256 ≥256 ≥256 ≥256 ≥256 ≥256 
piperacillin-  
tazobactam 
256 256 256 256 256 256 
a
minimum inhibitory concentration; 
b
Pseudomonas aeuroginos; 
s
pecial code for Pseudomonas aeroginosa imipenem 
resistant; 
d
 Imipenem 
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Table 2. Frequency of minimum inhibitory concentration (MIC mg/ml) of C. copticum , U. dioica, and Z. multiflora 
extracts for IMP-producing P.aeruginosa strains 
 
Forty eight (57.9%) patients were found to be 
infected with MBL-producing Pseudomonas 
isolates among which four (8.3%) died in the 
course of the study. Antibacterial activity of C. 
copticum, U. dioica, and Z. multiflora extracts 
against six IMP-producing P. aeruginosa 
isolates were determined by the micro dilution 
method as described by CLSI [20]. The results 
of MICs (mg/ml) for C. copticum, U. dioica, 
and Z. multiflora against IMP-producing P. 
aeruginosa strains are presented in Table 2. 
 
DISCUSSION 
     Although the use of antibiotics for treatment 
of clinical infections seems to be safe and 
effective, it has created several problems despite 
their benefits. With the expanding use of 
synthetic antibiotics, the number and type of 
bacterial resistance to drugs have been raised 
insofar as need for new antibacterial agents are 
indisputable. In addition to different progressed 
methods for obtaining new synthetic drugs, the 
use of herbal medicines for this approach can be 
considered valuable. Grappling with infectious 
diseases and emergence of resistant bacteria and 
the side effects of antibiotics explains the need for 
new antibacterial agents with natural origins. [21]. 
MBL producing isolates of P. aeruginosa are a 
main threat in hospitals and are a cause of high 
morbidity and mortality [22]. During the past two 
decades, P. aeruginosa was the most common 
bacteria among burn patients in Iran. P. 
aeruginosa strains studied in the present study 
appeared to be resistant to almost all antibacterial 
drugs. All MBL-producing P .aeruginosa were 
resistant to meropenem, imipenem, ceftazidime, 
ceftriaxone, cefepime, amikacin, tobramycin, 
ciprofloxacin, aztreonam, piperacillin/tazobactam, 
and carbenicillin. The prevalence of drug 
resistance in burn wards has been reported from 
other parts of the world, too [7, 23]. Several 
studies have demonstrated that the prevalence of 
MBL-encoding genes in P. aeruginosa strains can 
be different from one country to another [24]. 
Compared with other study, a higher prevalence 
of MBLs was found in our study. It can be 
attributable to various hospitalization time and 
treatment protocols [25-28]. The VIM beta-
lactamase in Iran, as is the case in the whole 
world, is the most type of MBL [29-31]. Other 
investigations in Iran reported VIM-type positive 
P. aeruginosa strains from Tehran and Ahwaz 
11.43% and 19.51% respectively. However, in the 
current study, IMP-1 producers of P. aeruginosa 
isolates were the most prevalent type among the 
strains studied, which is in contrast to findings 
reported in other studies [32-34]. In the present 
survey, 42% of strains were identified blaVIM and 
blaIMP negative; this resistance may be generated 
by other MBL encoding genes. Although 
mortality rate due to infection with MBL-
producing Pseudomonas isolates was reported 
82.6 % in Brazil, but in the current study was 4 
(8.3%) [35].These enzymes-encoding genes 
located on plasmids can easily spread resistance 
and, in outbreaks, can lead to failure in treatment 
and consequently result in mortality rates up to 
75% [36].There is few effective drugs against the 
MBL-producing P. aeruginosa. Consequently, it 
is safe to claim that there is a need to correct 
treatment protocols for resistant genes. Also, the 
antimicrobial effects of C. copticum, U. dioica, 
and Z. multiflora have been shown in many other 
studies [16, 17]. Nevertheless, antibacterial 
activity of these plants against IMP-producing P. 
aeruginosa isolates has not been reported yet. The 
present study confirms the idea that C. copticum, 
U. dioica, and Z. multiflora extracts can be useful 
as antibacterial agents on IMP-producing P. 
aeruginosa isolates. The acetonic and methanolic 
extracts of Z. multiflora, U. dioica, and C. 
copticum have hopeful MIC values on all IMP-
Z. multiflora U. dioica C. copyicum  
Acetone 
(mg/ml) 
Methanol 
(mg/ml) 
Acetone 
(mg/ml) 
Methanol 
(mg/ml) 
Acetone 
(mg/ml) 
Methanol 
(mg/ml) 
Strain 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH2IMP 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH22IMP 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH28IMP 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH40IMP 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH42IMP 
6.25 6.25 1.25 2.5 12.5 6.25 P.a FSH47IMP 
1.56 1.56 1.56 1.56 6.25 1.56 P.aeuginosa ATCC27853 
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producing P. aeruginosa strains. The results of the 
study by Proesto et al. showed that the methanolic 
extract of U. dioica on Staphylococcus aureus, 
Bacillus cereus, and Listeria monocytogenes has 
strong antibacterial activity [37]. In another 
investigation, Akrami et al. reported that P. 
aeruginosa was inhibited from 4% to 6% (w/w) of 
Zataria essential oil in the active coating [38]. 
Moreover, Azizkhani et al. have shown that The 
MIC and MBC of Z. multiflora Boiss against 
Staphylococcus were 0.03 and 0.04%, 
respectively [39]. In addition, the effective activity 
of ethanol extract of U. dioica against P 
.aerogenusa, E .coli, and S .aureus and 
Salmonella spp were investigated by Gorzalczany 
et al [37]. 
 
“The authors declare no conflict of interest” 
 
CONCLUSION 
     The prevalence of MBL-producing P. 
aeruginosa in hospitalized burn patients is high. 
Thus, evaluation of these strains has a major 
importance in the detection of antibiotic 
resistance patterns controlling P. aeruginosa 
infections. It was observed that the acetonic and 
methanolic extracts of Zataria multiflora, U. 
dioica and, C. copticum had a significant effect 
on clinical MBL-producing P. aeruginosa 
isolates.  
A natural drug with higher efficiency can be a 
good substitute for the chemical drugs, with all 
their side effects, commonly used in vivo 
investigations. Further studies should aim at 
introducing proper herbs that will help to 
produce such natural drugs. 
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